WHO ICTRP trial
The association of relative dose-intensity of Platinum-based doublet…
TCTR20231012010 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20231012010 |
|---|---|
| Public title | The association of relative dose-intensity of Platinum-based doublet chemotherapy and the survival outcome in Advanced stage Non-small cell lung cancer |
| Scientific title | The association of relative dose-intensity of Platinum-based doublet chemotherapy and the survival outcome in Advanced stage Non-small cell lung cancer |
| Primary sponsor | Department of Medicine, Maharat Nakhon Ratchasima Hospital |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | Thailand |
| Conditions | Non-small cell lung cancer Receiving Chemotherapy Non-small cell lung cancer Chemotherapy, Platinum-based Dosage Intensity Progression-Free Survival Retrospective Cohort Studies Kaplan-Meier Estimate Cox Proportional Hazards Models… |
| Interventions | NSCLC who receive platinum-based chemotherapy as a first-line treatment.;Treatment;Platinum based chemotherapy |
| Registration date | Dec 10, 2023 |
| Target size | 250 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: